All Articles

A new study shows Candela's Nordlys laser not only reverses skin aging at a DNA level but may also fight cancer, setting a new bar for the industry.

Beyond the recycling bin, a Kansas City non-profit is proving that large-scale composting is not just sustainable, but essential public infrastructure.

Kao USA's recall of its premium Oribe shampoo over bacterial contamination reveals the hidden operational risks that can undermine even top-tier brands.

The Association for Diagnostics & Laboratory Medicine's new leadership, led by Dr. Christina Lockwood, signals a decisive move to tackle healthcare's biggest challenges.

Hexaware's new Tensai® platform uses reasoning AI agents not just to solve IT problems faster, but to stop them from happening. Is this the dawn of autonomous IT?

With its new Tensai platform, Hexaware is betting that the future of IT isn't faster fixes, but a system that intelligently removes demand altogether.

Serial fitness entrepreneur Jamie Weeks is launching LiftHER, a women's-only strength studio, tackling a multi-billion dollar market where 73% of women are underserved.

Gartner's latest report signals a major shift. It's no longer just about AI writing code; it’s about managing the AI that does. We unpack the new era.

The retailer's back-to-back USA Today awards reveal a potent strategy, but a closer look shows the complex operational machine powering its celebrated success.

Triumph's new RFP Manager moves beyond static benchmarks, leveraging a vast network of live transaction data to give freight brokers confidence in a volatile market.

AstreaX's digital wallet now handles vehicle renewals on your phone. We analyze the tech, the Arizona rollout, and the security needed for true adoption.

NurExone's modest C$628k funding isn't a sign of weakness, but a masterclass in biotech survival. It's a strategic play in a cautious market.

The world's only lupus-focused fund is betting on a new model blending VC rigor with patient-led strategy. But can this ambitious structure deliver real progress?

As Pure Cycle preps for its Investor Day, a closer look reveals a unique strategy where water rights fuel land development and create a recurring revenue engine.

In a tough market, eQ secures nearly €1B in green loans, signaling deep lender confidence and arming its funds for future growth and acquisitions.

The world's top decking company is betting big on celebrity golf and Martha Stewart. It's a strategic pivot from selling boards to selling an aspirational lifestyle.

With a new U.S. patent, Quoin Pharmaceuticals reinforces its strategy for QRX003, a potential first-ever treatment for devastating Netherton Syndrome.

Zoomcar expands into motorcycle rentals, leveraging its asset-light model to tap a $1B market. Can it standardize a fragmented industry and win the daily commuter?

A new exclusive deal between Corpay and ticketing giant Fever reveals a critical truth: for global entertainment to scale, sophisticated finance is the star.